Arginase in the vascular endothelium: Friend or foe?

Frontiers in Immunology

Volumn 5, Issue NOV, 2014, Pages

  Lucas, Rudolf ^a   Fulton, David ^a   Caldwell, Robert William ^a   Romero, Maritza J ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Arginase inhibitors; eNOS; Impaired vasorelaxation; l citrulline; Microvascular permeability; Reactive oxygen species; Vessel wall remodeling

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE INHIBITOR; ARGININE; CITRULLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ALBUMINURIA; CAPILLARY ENDOTHELIAL CELL; CELL PROLIFERATION; CLINICAL TRIAL (TOPIC); EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME INDUCTION; HOMEOSTASIS AND REGULATION; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; NONHUMAN; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 84919433388     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2014.00589     Document Type: Editorial

References (21)

1. Romero MJ, Yao L, Sridhar S, Bhatta A, Dou H, Ramesh G, et al. l-Citrulline protects from kidney damage in type 1 diabetic mice. Front Immunol (2013) 4:480. doi: 10.3389/fimmu.2013.00480
2. Toque HA, Nunes KP, Rojas M, Bhatta A, Yao L, Xu Z, et al. Arginase 1 mediates increased blood pressure and contributes to vascular endothelial dysfunction in deoxycorticosterone acetate-salt hypertension. Front Immunol (2013) 4:219. doi:10.3389/fimmu.2013.00219
3. Johnson FK, Johnson RA, Peyton KJ, Shebib AR, Durante W. Arginase promotes skeletal muscle arteriolar endothelial dysfunction in diabetic rats. Front Immunol (2013) 4:119. doi:10.3389/fimmu.2013.00119
4. Patel C, Rojas M, Narayanan SP, Zhang W, Xu Z, Lemtalsi T, et al. Arginase as a mediator of diabetic retinopathy. Front Immunol (2013) 4:173. doi:10.3389/fimmu.2013.00173
5. Durante W. Role of arginase in vessel wall remodeling. Front Immunol (2013) 4:111. doi:10.3389/fimmu.2013.00111
6. Lucas R, Czikora I, Sridhar S, Zemskov EA, Oseghale A, Circo S, et al. Arginase 1: an unexpected mediator of pulmonary capillary barrier dysfunction in models of acute lung injury. Front Immunol (2013) 4:228. doi:10.3389/fimmu.2013.00228
7. Yang Z, Ming XF. Arginase: the emerging therapeutic target for vascular oxidative stress and inflammation. Front Immunol (2013) 4:149. doi:10.3389/fimmu.2013.00149
8. Chen F, Lucas R, Fulton D. The subcellular compartmentalization of arginine metabolizing enzymes and their role in endothelial dysfunction. Front Immunol (2013) 4:184. doi:10.3389/fimmu.2013.00184
9. Madigan M, Zuckerbraun B. Therapeutic potential of the nitrite-generated NO pathway in vascular dysfunction. Front Immunol (2013) 4:174. doi:10.3389/fimmu.2013.00174
10. Bagi Z, Feher A, Dou H, Broskova Z. Selective up-regulation of arginase-1 in coronary arteries of diabetic patients. Front Immunol (2013) 4:293. doi:10.3389/fimmu.2013.00293
11. Kuo L, Hein TW. Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase. Front Immunol (2013) 4:237. doi:10.3389/fimmu.2013.00237
12. Steppan J, Nyhan D, Berkowitz DE. Development of novel arginase inhibitors for therapy of endothelial dysfunction. Front Immunol (2013) 4:278. doi:10.3389/fimmu.2013.00278
13. Li H, Meininger CJ, Hawker JR Jr, Haynes TE, Kepka-Lenhart D, Mistry SK, et al. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab (2001) 280(1):E75-82.
14. Pernow J, Jung C. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc Res (2013) 98(3):334-43. doi:10.1093/cvr/cvt036
15. Gao X, Xu X, Belmadani S, Park Y, Tang Z, Feldman AM, et al. TNF-alpha contributes to endothelial dysfunction by upregulating arginase in ischemia/reperfusion injury. Arterioscler Thromb Vasc Biol (2007) 27(6):1269-75. doi:10.1161/ATVBAHA.107.142521
16. Katusic ZS. Mechanisms of endothelial dysfunction induced by aging: role of arginase I. Circ Res (2007) 101(7):640-1. doi:10.1161/CIRCRESAHA.107.162701
17. Lucas R, Lou J, Morel DR, Ricou B, Suter PM, Grau GE. TNF receptors in the microvascular pathology of acute respiratory distress syndrome and cerebral malaria. J Leukoc Biol (1997) 61(5):551-8.
18. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol (2005) 289:L371-81. doi:10.1152/ajplung.00175.2004
19. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, et al. l-arginine therapy in acute myocardial infarction: the vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial. JAMA (2006) 295(1):58-64. doi:10.1001/jama.295.1.58
20. Ochoa JB, Bernard AC, O'Brien WE, Griffen MM, Maley ME, Rockich AK, et al. Arginase I expression and activity in human mononuclear cells after injury. Ann Surg (2001) 233(3):393-9. doi:10.1097/00000658-200103000-00014
21. Liu Y, Gardner CR, Laskin JD, Laskin DL. Classical and alternative activation of rat hepatic sinusoidal endothelial cells by inflammatory stimuli. Exp Mol Pathol (2013) 94(1):160-7. doi:10.1016/j.yexmp.2012.10.015